We are live on ! Find out more
CLPT icon

ClearPoint Neuro

78 hedge funds and large institutions have $76.5M invested in ClearPoint Neuro in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more capital invested

Capital invested by funds: $38M → $76.5M (+$38.5M)

46% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $695K

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

1% less ownership

Funds ownership: 25.73%24.73% (-1%)

9% less funds holding

Funds holding: 8678 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
78
Holders Change
-8
Holders Change %
-9.3%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
21
Reduced
21
Closed
22
Calls
$1.02M
Puts
$695K
Net Calls
+$321K
Net Calls Change
+$262K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$13.9M +$255K +26,627 +2%
EIM
2
Essex Investment Management
Massachusetts
$5.2M +$12.1K +1,267 +0.3%
TFCM
3
Taylor Frigon Capital Management
Arizona
$4.2M -$476K -49,738 -12%
BlackRock
4
BlackRock
New York
$4.17M +$49.8K +5,203 +1%
Brown Advisory
5
Brown Advisory
Maryland
$3.74M
CM
6
CM Management
Florida
$3.36M -$718K -75,000 -20%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$3.22M +$39.9K +4,170 +1%
Marshall Wace
8
Marshall Wace
United Kingdom
$3.1M +$2.09M +218,372 +375%
Millennium Management
9
Millennium Management
New York
$3.09M -$1.82M -190,197 -41%
CWM
10
Cahill Wealth Management
Michigan
$2.74M +$335 +35 +0%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$2.53M +$1.4M +146,489 +185%
LCM
12
Legato Capital Management
California
$1.78M
LG
13
Lane Generational
Massachusetts
$1.77M -$113K -11,822 -7%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$1.69M +$732K +76,408 +102%
CCM
15
Conway Capital Management
California
$1.59M +$1.35M +141,500 New
PCM
16
Parsons Capital Management
Rhode Island
$1.56M +$317K +33,100 +31%
Qube Research & Technologies (QRT)
17
Qube Research & Technologies (QRT)
United Kingdom
$1.4M +$696K +72,668 +140%
State Street
18
State Street
Massachusetts
$1.18M -$233K -24,300 -19%
Jane Street
19
Jane Street
New York
$1.13M -$410K -42,851 -30%
Citigroup
20
Citigroup
New York
$1.02M +$763K +79,729 +736%
Citadel Advisors
21
Citadel Advisors
Florida
$963K -$949K -99,078 -54%
EI
22
EAM Investors
California
$886K +$756K +78,992 New
MHP
23
Manatuck Hill Partners
Connecticut
$841K
TI
24
Trexquant Investment
Connecticut
$797K +$260K +27,190 +62%
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$758K +$23K +2,400 +4%

CLPT Hedge Fund Activity: Q3 2024 in Review

78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2024, worth a combined $76.5M — up 101% from $38M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CLPT and 14 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 21 added.

The largest buyer was Marshall Wace, adding an estimated $2.09M. The largest seller was Millennium Management, cutting an estimated $1.82M.

  • 78 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2024, down from 86 in Q2 2024.
  • Funds reported $76.5M of ClearPoint Neuro stock for Q3 2024, up 101% quarter-over-quarter.
  • 14 funds opened new ClearPoint Neuro positions in Q3 2024 and 22 closed out, a net change of -8 holders.
  • The largest ClearPoint Neuro buyer in Q3 2024 was Marshall Wace, an estimated $2.09M added.
  • The largest ClearPoint Neuro seller in Q3 2024 was Millennium Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q3 2024.